Biography
Shaker A Mousa finished his PhD from Ohio State University, College of Medicine, Columbus, OH and Post-doctoral Fellowship, University of Kentucky, Lexington KY. He also received his MBA from Widener University, Chester, PA. He is currently an endowed tenure Professor and Executive Vice President and Chairman of the Pharmaceutical Research Institute and Vice Provost for Research at ACPHS. Prior to his academic career, he was a senior Scientist and fellow at The DuPont Pharmaceutical Company for 17 years, where he contributed to the discovery and development of several FDA approved and globally marketed diagnostics and therapeutics. He holds over 350 US and International Patents discovering novel anti-angiogenesis strategies, antithrombotics, anti-integrins, anti-cancer, and non-invasive diagnostic imaging approaches employing various nanotechnology platforms. His has published more than 1,000 journal articles, book chapters, published patents, and books as editor and author. He is a member of several NIH study sections, and the Editorial Board Member of several high impact Journals. His research has focused on diagnostics and therapeutics of angiogenesis-related disorders, thrombosis, vascular and cardiovascular diseases.
Research Interest
Dr. Mousa's current research interests include: Adhesion molecules in health and diseases, Novel therapeutic and diagnostic targets, Treatment and prevention of ischemic and coronary artery diseases, Angiogenesis modulation, vascular and tissue remodeling, and novel anti-platelet, anti-thrombotic and anti-ischemic therapies. Dr. Mousa received a Ph.D. in Pharmacology from The Ohio State University, completed postdoctoral research in Cardiovascular Pharmacology at the University of Kentucky and earned his MBA from Widener University. A native of Alexandria, Egypt, he received his B.Pharm. and M.Sc. degrees from Alexandria University. He was elected a fellow of the American College of Cardiology (FACC) and a fellow of the National Academy of Clinical Biochemistry (FACB), and is a member of several national and international societies. He was recently awarded grants through the U.S. Department of Defense and the National Institute of Health.
Biography
Dr. Hussein Ammar, Holder of the First Class Golden Medal for Sciences and Arts and the recipient of the 2010 Appreciation State Prize in the realm of Advanced Technological Sciences. Professor Ammar is currently the Chairman, Pharmaceutical Technology Department, Faculty of Pharmaceutical Sciences and Pharmaceutical Industries, Future University in Egypt; formerly, Dean of the Pharmacy Division, National Research Centre, Cairo, Egypt. He has 123 research papers published in international scientific journals. These research papers cover most of the areas related to pharmaceutics, biopharmaceutics and pharmacokinetics. Design of new drug delivery systems is not beyond the scope of his interest.
Research Interest
His research interest is on drug delivery systems
Biography
Dr. Mary Mehrnoosh Eshaghian-Wilner is an interdisciplinary scientist and patent attorney with over 26 years of research experience. She has published hundreds of scientific articles, including three books, and has handled the prosecution and infringement analysis of many complex U.S. and international patents. Dr. Eshaghian-Wilner currently is a Professor of Engineering Practice at the Electrical Engineering-Systems Department in the University of Southern California (USC). Professor Eshaghian-Wilner has founded and/or chaired numerous IEEE conferences and organizations, including the IEEE Women in Engineering affinity division of the Coastal Los Angeles Section. Awards : 2016 Prof. Eshaghian-Wilner is the recipient of several prestigious grants and honors.
Research Interest
Computing Architectures and Interconnects: Bio-inspired and Nanoscale Computing, MEMS, Optical Interconnects, VLSI and Reconfigurable chips -Computing Networks and Algorithms: Heterogeneous/Cluster/Grid/Cloud Computing, Mapping and Scheduling paradigms/algorithms/tools -Biomedical Applications: Nanomedicine, Bioinformatics, Sequence Alignment, Image-Processing, Computer Vision -Technology Law: Technology Transfer, Intellectual Property, Patent Reform, Digital Rights, Cyber Law/Crimes, Internet Privacy